Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689535019 | Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689537010 | Ceftazidime (as ceftazidime pentahydrate) 500 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Is a | Product containing ceftazidime (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Is a | Product containing ceftazidime (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Ceftazidime (substance) | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Is a | Ceftazidime-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for solution for injection | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has basis of strength substance (attribute) | Ceftazidime (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 1 | |
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has precise active ingredient | Ceftazidime pentahydrate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Is a | Ceftazidime only product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR